XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities        
Net income for the period $ 264,000,000 $ 828,000,000 $ 488,000,000 $ 726,000,000
Adjustments to reconcile net income to net cash provided by operating activities:        
Amortization and depreciation 8,000,000 8,000,000 24,000,000 28,000,000
Stock-based compensation 107,000,000 110,000,000 334,000,000 321,000,000
Impairment of right-of-use assets and leasehold improvements 3,000,000 0 13,000,000 0
Provision for transaction and loan losses 102,000,000 42,000,000 189,000,000 96,000,000
Deferred income tax (recovery) expense (5,000,000) 3,000,000 (36,000,000) 6,000,000
Revenue related to non-cash consideration (12,000,000) (19,000,000) (37,000,000) (75,000,000)
Unrealized loss on embedded derivative 29,000,000 0 29,000,000 0
Net loss (gain) on equity and other investments 62,000,000 (512,000,000) 401,000,000 (63,000,000)
Net loss on equity method investment 21,000,000 28,000,000 68,000,000 116,000,000
Unrealized foreign exchange loss (gain) 4,000,000 (19,000,000) (54,000,000) (15,000,000)
Changes in operating assets and liabilities (70,000,000) (46,000,000) (111,000,000) (139,000,000)
Net cash provided by operating activities 513,000,000 423,000,000 1,308,000,000 1,001,000,000
Cash flows from investing activities        
Purchases of property and equipment (6,000,000) (2,000,000) (16,000,000) (15,000,000)
Purchases of marketable securities (1,460,000,000) (2,086,000,000) (4,642,000,000) (6,057,000,000)
Maturities of marketable securities 1,956,000,000 1,837,000,000 4,751,000,000 5,647,000,000
Purchases and originations of loans (996,000,000) (844,000,000) (2,745,000,000) (2,129,000,000)
Repayments and sales of loans 849,000,000 628,000,000 2,253,000,000 1,767,000,000
Purchases of equity and other investments (8,000,000) (4,000,000) (83,000,000) (111,000,000)
Acquisition of business, net of cash acquired 0 (4,000,000) (56,000,000) (30,000,000)
Other 0 1,000,000 2,000,000 3,000,000
Net cash provided by (used in) investing activities 335,000,000 (474,000,000) (536,000,000) (925,000,000)
Cash flows from financing activities        
Proceeds from the exercise of stock options 24,000,000 6,000,000 127,000,000 12,000,000
Net cash provided by financing activities 24,000,000 6,000,000 127,000,000 12,000,000
Effect of foreign exchange on cash, cash equivalents and restricted cash 0 11,000,000 17,000,000 6,000,000
Net increase (decrease) in cash, cash equivalents and restricted cash 872,000,000 (34,000,000) 916,000,000 94,000,000
Cash, cash equivalents and restricted cash – beginning of period 1,542,000,000 1,541,000,000 1,498,000,000 1,413,000,000
Cash, cash equivalents and restricted cash – end of period 2,414,000,000 1,507,000,000 2,414,000,000 1,507,000,000
Supplemental cash flow information:        
Cash paid for income taxes, net $ 23,000,000 $ 14,000,000 $ 111,000,000 $ 63,000,000